메뉴 건너뛰기




Volumn 4, Issue 6, 2015, Pages 313-315

Physiologically based pharmacokinetics is impacting drug development and regulatory decision making

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CLINICAL DECISION MAKING; CLINICAL PHARMACOLOGY; COMPARTMENT MODEL; COMPUTER MODEL; CONCEPTUAL FRAMEWORK; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INDUSTRY; DRUG INTERACTION; DRUG METABOLISM; EUROPEAN MEDICINES AGENCY; FOOD AND DRUG ADMINISTRATION; GENETIC POLYMORPHISM; GERMLINE MUTATION; HUMAN; IN VITRO STUDY; INTRINSIC CLEARANCE; KIDNEY FUNCTION; LIVER CLEARANCE; PHARMACOGENOMICS; PHARMACOKINETICS; PHYSIOLOGICALLY BASED PHARMACOKINETICS; PRIORITY JOURNAL; PUBLICATION; REVIEW; TISSUE DISTRIBUTION;

EID: 84936773921     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1002/psp4.52     Document Type: Review
Times cited : (49)

References (4)
  • 1
    • 84936751860 scopus 로고    scopus 로고
    • Application of physiologically-based pharmacokinetic (PBPK) modeling to support dose selection - Report of a FDA public workshop on PBPK
    • Wagner, C,. et al. Application of physiologically-based pharmacokinetic (PBPK) modeling to support dose selection-report of a FDA public workshop on PBPK. CPT Pharmacometrics Syst. Pharmacol 4, 226-230 (2015).
    • (2015) CPT Pharmacometrics Syst. Pharmacol , vol.4 , pp. 226-230
    • Wagner, C.1
  • 2
    • 84936752860 scopus 로고    scopus 로고
    • Physiologically based models in regulatory submissions: Output from the ABPI/MHRA Forum on Physiologically Based Modelling and Simulation
    • (2015)
    • Shepard, T., Scott, G., Cole, S., Nordmark, A., &, Bouzom, F,. Physiologically based models in regulatory submissions: output from the ABPI/MHRA Forum on Physiologically Based Modelling and Simulation. CPT Pharmacometrics Syst. Pharmacol 4, 221-225 (2015).
    • CPT Pharmacometrics Syst. Pharmacol , vol.4 , pp. 221-225
    • Shepard, T.1    Scott, G.2    Cole, S.3    Nordmark, A.4    Bouzom, F.5
  • 3
    • 84936790666 scopus 로고    scopus 로고
    • Concept paper on qualification and reporting of physiologically based pharmacokinetic (PBPK) modelling and analyses. EMA/CHMP/211243/2014
    • Concept paper on qualification and reporting of physiologically based pharmacokinetic (PBPK) modelling and analyses. EMA/CHMP/211243/2014.
  • 4
    • 0003556719 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Food and Drug Administration, Washington DC Accessed 16 April 2015
    • Guidance for Industry: Population Pharmacokinetics. U.S. Department of Health and Human Services, Food and Drug Administration, Washington DC. < http://www.fda.gov/downloads/Drugs/Guidances/UCM072137.pdf > (1999). Accessed 16 April 2015.
    • (1999) Guidance for Industry: Population Pharmacokinetics


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.